China Medical & HealthCare Group Limited provided unaudited consolidated guidance for the five months ended May 31, 2022. For the period, the Group is expected to record a Net Loss for the five months ended 31 May 2022 which represents an approximately 316% increase as compared with the Net Loss for the corresponding period in 2021; an approximately 40% to 50% decrease, when compared with the Net Loss for the six months, ended 30 June 2021; or an approximately 77% to 87% increase, when compared with the Net Loss for the six months, ended 30 June 2021 excluding the one-off non-recurring item of impairment loss recognized on loan receivable.